Braze (BRZE) 10-Q 6 Dec 23 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Oct. 31, 2023	Nov. 30, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2023
Document Transition Report	false
Entity File Number	001-41065
Entity Registrant Name	Braze, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	45-2505271
Entity Address, Address Line One	330 West 34th Street
Entity Address, Address Line Two	Floor 18
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10001
City Area Code	609
Local Phone Number	964-0585
Title of 12(b) Security	Class A Common Stock, par value $0.0001 per share
Trading Symbol	BRZE
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001676238
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		68,582,697
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		31,259,737

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 60,470	$ 68,587
Restricted cash, current	3,373	0
Accounts receivable, net of allowance of $2,804 and $1,613 at October 31, 2023 and January 31, 2023, respectively	71,332	78,338
Marketable securities	407,500	410,083
Prepaid expenses and other current assets	24,077	26,163
Total current assets	566,752	583,171
Restricted cash, noncurrent	530	4,036
Property and equipment, net	22,853	20,339
Operating lease right-of-use assets	84,179	46,261
Deferred contract costs	59,251	48,451
Goodwill	28,112	0
Intangible assets, net	3,907	500
Other assets	3,331	2,648
TOTAL ASSETS	768,915	705,406
CURRENT LIABILITIES:
Accounts payable	5,947	3,101
Accrued expenses and other current liabilities	49,758	37,415
Deferred revenue	178,564	166,092
Operating lease liabilities, current	14,070	10,695
Total current liabilities	248,339	217,303
Operating lease liabilities, noncurrent	76,967	40,590
Other long-term liabilities	4,878	755
TOTAL LIABILITIES	330,184	258,648
COMMITMENTS AND CONTINGENCIES (Note 13)
Redeemable non-controlling interest (Note 4)	493	1,455
STOCKHOLDERS’ EQUITY
Additional paid-in capital	898,229	806,044
Accumulated other comprehensive loss	(5,185)	(6,824)
Accumulated deficit	(454,816)	(353,927)
TOTAL STOCKHOLDERS’ EQUITY	438,238	445,303
TOTAL LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND STOCKHOLDERS’ EQUITY	768,915	705,406
Class A common stock
STOCKHOLDERS’ EQUITY
Common stock	7	6
Class B common stock
STOCKHOLDERS’ EQUITY
Common stock	$ 3	$ 4

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Allowance for doubtful accounts	$ 2,804	$ 1,613
Class A common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	2,000,000,000	2,000,000,000
Common stock, issued (in shares)	67,888,269	61,585,973
Common stock, outstanding (in shares)	67,888,269	61,585,973
Class B common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	110,000,000	110,000,000
Common stock, issued (in shares)	31,321,234	34,389,453
Common stock, outstanding (in shares)	31,321,234	34,389,453

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Income Statement [Abstract]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 123,956	$ 93,125	$ 340,843	$ 256,751
Cost of Revenue	36,374	29,135	104,535	82,393
Gross Profit, Total	87,582	63,990	236,308	174,358
Operating Expenses [Abstract]
Selling and Marketing Expense	66,395	52,841	184,074	148,892
Research and Development Expense	29,872	25,583	88,749	70,539
General and Administrative Expense	26,448	22,430	75,884	66,547
Operating Expenses, Total	122,715	100,854	348,707	285,978
Operating Income (Loss), Total	(35,133)	(36,864)	(112,399)	(111,620)
Other Nonoperating Income (Expense)	4,542	2,581	11,866	4,340
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	(30,591)	(34,283)	(100,533)	(107,280)
Income Tax Expense (Benefit)	385	(391)	1,318	(342)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total	(30,976)	(33,892)	(101,851)	(106,938)
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest	(235)	(532)	(962)	(1,423)
Net Income (Loss) Attributable to Parent, Total	$ (30,741)	$ (33,360)	$ (100,889)	$ (105,515)
Earnings Per Share
Net loss per share attributable to Braze, Inc. common stockholders, basic (in dollars per share)	$ (0.31)	$ (0.35)	$ (1.03)	$ (1.12)
Net loss per share attributable to Braze, Inc. common stockholders, diluted (in dollars per share)	$ (0.31)	$ (0.35)	$ (1.03)	$ (1.12)
Weighted-Average Shares Outstanding
Weighted-average shares used to compute net loss per share attributable to Braze, Inc. common stockholders, basic (in shares)	97,880	94,469	97,615	94,168
Weighted-average shares used to compute net loss per share attributable to Braze, Inc. common stockholders, diluted (in shares)	97,880	94,469	97,615	94,168

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Statement of Comprehensive Income [Abstract]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ (30,976)	$ (33,892)	$ (101,851)	$ (106,938)
Other comprehensive loss:
Change in foreign currency translation adjustments	(368)	(520)	(172)	(1,275)
Unrealized gains (losses) on marketable securities	1,060	(5,591)	1,811	(7,950)
Other comprehensive income (loss), net	692	(6,111)	1,639	(9,225)
Comprehensive loss, net	(30,284)	(40,003)	(100,212)	(116,163)
Less: comprehensive loss, net, attributable to redeemable non-controlling interest	(235)	(532)	(962)	(1,423)
Comprehensive loss attributable to Braze, Inc.	$ (30,049)	$ (39,471)	$ (99,250)	$ (114,740)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Convertible Preferred Stock, Redeemable Noncontrolling Interest and Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Class A and Class B Common Stock	Class A and Class B Common Stock Common Class A And B	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Jan. 31, 2022	$ 3,235
Noncontrolling Interest [Roll Forward]
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest	(1,423)
Ending balance at Oct. 31, 2022	1,812
Beginning balance (in shares) at Jan. 31, 2022			92,968,000
Beginning balance at Jan. 31, 2022	501,583		$ 9	$ 717,175	$ (214,961)	$ (640)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for options exercised (in shares)			1,814,000
Issuance of common stock for options exercised	7,213			7,213
Vesting of early exercised options	171			171
Vesting of restricted stock units (in shares)			408,000
Repurchase of shares related to early exercised options (in shares)			(1,000)
Stock-based compensation	53,915			53,915
Other comprehensive income	(9,225)					(9,225)
Charitable donation of stock (in shares)			96,000
Charitable donation of stock	4,260			4,260
Net Income (Loss)	(105,515)				(105,515)
Ending balance at Oct. 31, 2022	452,402	$ 9	$ 9	782,734	(320,476)	(9,865)
Ending balance (in shares) at Oct. 31, 2022		95,285,000	95,285,000
Beginning balance at Jul. 31, 2022	2,344
Noncontrolling Interest [Roll Forward]
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest	(532)
Ending balance at Oct. 31, 2022	1,812
Beginning balance (in shares) at Jul. 31, 2022			94,717,000
Beginning balance at Jul. 31, 2022	470,551		$ 9	761,412	(287,116)	(3,754)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for options exercised (in shares)			398,000
Issuance of common stock for options exercised	1,802			1,802
Vesting of early exercised options	89			89
Vesting of restricted stock units (in shares)			170,000
Stock-based compensation	19,431			19,431
Other comprehensive income	(6,111)					(6,111)
Net Income (Loss)	(33,360)				(33,360)
Ending balance at Oct. 31, 2022	452,402	$ 9	$ 9	782,734	(320,476)	(9,865)
Ending balance (in shares) at Oct. 31, 2022		95,285,000	95,285,000
Beginning balance at Jan. 31, 2023	1,455
Noncontrolling Interest [Roll Forward]
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest	(962)
Ending balance at Oct. 31, 2023	493
Beginning balance (in shares) at Jan. 31, 2023			95,975,000
Beginning balance at Jan. 31, 2023	445,303		$ 10	806,044	(353,927)	(6,824)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for options exercised (in shares)			1,664,000
Issuance of common stock for options exercised	5,949			5,949
Issuance of common stock under employee stock purchase plan (in shares)			128,000
Issuance of common stock under employee stock purchase plan	3,222			3,222
Vesting of restricted stock units (in shares)			1,189,000
Stock-based compensation	74,502			74,502
Other comprehensive income	1,639					1,639
Charitable donation of stock (in shares)			64,000
Charitable donation of stock	2,391			2,391
Issuance of common stock from acquisition (in shares)			190,000
Stock Issued During Period, Value, Acquisitions	6,121			6,121
Net Income (Loss)	(100,889)				(100,889)
Ending balance at Oct. 31, 2023	438,238		$ 10	898,229	(454,816)	(5,185)
Ending balance (in shares) at Oct. 31, 2023			99,210,000
Beginning balance at Jul. 31, 2023	728
Noncontrolling Interest [Roll Forward]
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest	(235)
Ending balance at Oct. 31, 2023	493
Beginning balance (in shares) at Jul. 31, 2023			98,230,000
Beginning balance at Jul. 31, 2023	440,371		$ 10	870,313	(424,075)	(5,877)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for options exercised (in shares)			415,000
Issuance of common stock for options exercised	1,838			1,838
Vesting of restricted stock units (in shares)			533,000
Stock-based compensation	24,530			24,530
Other comprehensive income	692					692
Charitable donation of stock (in shares)			32,000
Charitable donation of stock	1,427			1,427
Issuance of common stock from acquisition (in shares)			0
Stock Issued During Period, Value, Acquisitions	121			121
Net Income (Loss)	(30,741)				(30,741)
Ending balance at Oct. 31, 2023	$ 438,238		$ 10	$ 898,229	$ (454,816)	$ (5,185)
Ending balance (in shares) at Oct. 31, 2023			99,210,000

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ (101,851)	$ (106,938)
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Share-Based Payment Arrangement, Noncash Expense	72,961	53,394
Capitalized Contract Cost, Amortization	21,684	17,248
Cost, Depreciation and Amortization	5,082	2,926
Accounts Receivable, Credit Loss Expense (Reversal)	1,717	328
Noncash Contribution Expense	2,391	4,260
Amortization of Debt Discount (Premium)	1,579	753
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax	473	1,669
Other Noncash Income (Expense)	136	(300)
Increase (Decrease) in Operating Capital [Abstract]
Increase (Decrease) in Accounts Receivable	7,269	5,877
Increase (Decrease) in Prepaid Expense and Other Assets	1,946	5,090
Increase (Decrease) In Capitalized Contract Cost, Net	(32,609)	(21,223)
Increase (Decrease) In Right Of Use Assets And Liabilities	1,903	2,490
Increase (Decrease) in Other Noncurrent Assets	(324)	1,033
Increase (Decrease) in Accounts Payable	2,859	26
Increase (Decrease) in Accrued Liabilities	9,321	(3,399)
Increase (Decrease) in Contract with Customer, Liability	8,363	14,421
Increase (Decrease) in Other Noncurrent Liabilities	129	25
Net Cash Provided by (Used in) Operating Activities, Total	3,029	(22,320)
Net Cash Provided by (Used in) Investing Activities [Abstract]
Payments to Acquire Businesses, Net of Cash Acquired	(16,319)	0
Payments to Acquire Property, Plant, and Equipment	(3,439)	(14,066)
Payments to Develop Software	(2,536)	(705)
Payments to Acquire Debt Securities, Available-for-Sale	(191,922)	(614,878)
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale	194,737	213,107
Net Cash Provided by (Used in) Investing Activities, Total	(19,479)	(416,542)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Proceeds from exercise of common stock options	5,949	7,213
Proceeds from stock associated with employee stock purchase plan	3,222	0
Payments of deferred purchase consideration	(165)	0
Net cash provided by financing activities	9,006	7,213
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(806)	(1,898)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	(8,250)	(433,547)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance	72,623	482,973
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Ending Balance	64,373	49,426
SUPPLEMENTAL CASH FLOW DISCLOSURE:
Cash paid for income taxes, net of refunds	182	327
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock-based compensation capitalized to internal-use software	1,516	796
Net change in capitalized internal-use software development costs in accrued expenses	0	21
Unrealized net gain (loss) on marketable investment securities	(1,811)	(7,950)
Net change to property and equipment (included in accounts payable / accrued liabilities)	(8)	5
Vesting of early exercised options	0	171
Asset retirement obligation	17	348
Common stock issuance, acquisition	(6,121)	0
Contingent consideration, acquisition	(1,795)	0
Indemnity holdbacks, acquisition	$ (2,965)	$ 0

Company Overview

Company Overview	9 Months Ended
	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Company Overview	Company Overview Description of Business Braze, Inc., together with its subsidiaries (collectively, the “Company”, “we”, “us”, “our” or “Braze”), is a cloud-based customer engagement platform that delivers customer-centric experiences across push notifications, email, in-product messaging, SMS and MMS messages, and more. Customers use the Braze platform to facilitate real-time experiences between brands and customers in a more authentic and human way. We began operations in 2011 and are incorporated in the state of Delaware. Our headquarters are located in New York City. As of October 31, 2023, we also lease additional office space in Austin, Berlin, Chicago, Jakarta, London, Paris, San Francisco, Singapore, Sydney, and Tokyo.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, and variable interest entities (“VIE”) for which we are the primary beneficiary. Intercompany balances and transactions have been eliminated in consolidation. Reclassifications Certain reclassifications and immaterial changes have been made to prior-period financial statements to conform to the current-period presentation. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reported period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Significant items subject to such estimates and assumptions include, but are not limited to, the standalone selling price for separate performance obligations in our revenue arrangements, expected period of benefit for deferred contract costs, the valuation of common stock and stock-based compensation, the allocation of overhead costs between cost of revenue and operating expenses, the estimated useful lives of intangible and depreciable assets, the fair value of acquired assets and assumed liabilities from business combinations, valuation of long-lived assets and their recoverability, including goodwill, the incremental borrowing rate, the valuation of deferred tax assets and liabilities and other tax estimates including our ability to utilize net operating losses. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments as facts and circumstances dictate. As future events and their effects, including the uncertainty surrounding rapidly changing market and economic conditions from global or domestic macroeconomic and socioeconomic events such as, among others, instability in the banking and financial services sector, international and domestic supply chain risks, inflationary pressure, interest rate increases, declines in consumer confidence, international conflicts and domestic and foreign political unrest, that impact us and our customers, cannot be determined with precision, actual results could differ from those estimates and many of our estimates and assumptions have required increased judgement and carry a higher degree of variability and volatility. Significant Accounting Policies Our significant accounting policies are detailed in “Note 2. Summary of Significant Accounting Policies" of the audited annual consolidated financial statements for the fiscal year ended January 31, 2023 included in the Company’s Annual Report on Form 10-K, as filed with the SEC on March 31, 2023 (the “Annual Report”). T here have been no material changes to our significant accounting policies with the exception of the below: Concentration of Credit Risk Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents, restricted cash, marketable securities, and accounts receivable. Restricted cash consists of letters of credit related to our leased properties. For cash, cash equivalents, restricted cash, and marketable securities, we are exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the consolidated balance sheets in excess of the Federal Deposit Insurance Corporation (“FDIC”) limits. Cash, cash equivalents, restricted cash, and marketable securities balances are maintained at financial institutions that management believes are of high-credit, quality financial institutions, where deposits, at times, exceed the FDIC limits. Significant customers are those which represent 10% or more of our total revenue for the period, or accounts receivable at the balance sheets dates. For the three and nine months ended October 31, 2023 and October 31, 2022, no customer accounted for 10% or more of our total revenue. For accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the consolidated balance sheets. As of October 31, 2023 and January 31, 2023, no customers accounted for 10% or more of our total accounts receivable balance. Business Combinations The Company recognizes identifiable assets acquired and liabilities assumed at their acquisition date fair values. The excess of the consideration transferred over the fair value of assets acquired and liabilities assumed on the acquisition date is recorded as goodwill. Such valuations require the Company to make significant estimates and assumptions. The Company uses its best estimates and assumptions as part of the purchase price allocation process to accurately value assets acquired and liabilities assumed, but these estimates are inherently uncertain and subject to refinement. During the measurement period, the Company may record adjustments to the fair values of assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded in the consolidated statements of operations. Goodwill and Indefinite-Lived Intangible Assets Goodwill represents the excess of the aggregate purchase price over the fair value of net identifiable assets acquired in a business combination. Goodwill and indefinite-lived intangible assets are not amortized and are tested for impairment at least annually or whenever events or changes in circumstances indicate that the carrying value may be impaired. Goodwill is tested for impairment at the reporting unit level. The Company has the option to first perform a qualitative assessment to determine if it is more likely than not that the fair value of a reporting unit and indefinite-lived intangible assets are less than its carrying amount. The Company may elect to bypass the qualitative assessment and proceed directly to the quantitative impairment tests. The quantitative impairment test for goodwill involves comparing the fair value of the reporting unit to its carrying value, including goodwill. A goodwill impairment will be the amount by which a reporting unit’s carrying value exceeds its fair value. The impairment is limited to the carrying amount of goodwill. The quantitative impairment test for indefinite-lived intangible assets involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the indefinite-lived intangible asset exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. The estimates of fair value of indefinite-lived intangible assets are determined using a discounted cash flow valuation analysis that employs different valuation methodology in estimating the fair value of the asset. Significant judgments are inherent in the discounted cash flow analysis. The Company has determined that it operates as one reporting unit and has selected November 1 as the date to perform its annual impairment test. No goodwill impairment charges have been recorded for any period presented. Recent Accounting Pronouncements In October 2021, the Financial Accounting Standards Board issued Accounting Standards Update No. 2021-08 Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, (“ASU 2021-08”), which requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. The Company adopted ASU 2021-08 prospectively during the second quarter of the fiscal year ended January 31, 2024, and determined that ASU 2021-08 does not have a material impact on the Company’s consolidated financial statements nor its related disclosures. The Company has implemented all applicable accounting pronouncements that are in effect and there are no new accounting pronouncements that have been issued that would have a material impact on the Company's condensed consolidated financial statements.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	9 Months Ended
	Oct. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	Revenue from Contracts with Customers Disaggregated Revenue Streams The following disaggregation depicts the nature, amount, timing and uncertainty of cash flows related to the primary types of revenue from contracts with customers. The following table presents total revenue by type (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Subscription $ 118,345 $ 88,982 $ 325,202 $ 243,545 Professional services and other 5,611 4,143 15,641 13,206 Total $ 123,956 $ 93,125 $ 340,843 $ 256,751 The following table presents total revenue by geography (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 United States $ 69,724 $ 53,259 $ 193,341 $ 148,486 International 54,232 39,866 147,502 108,265 Total $ 123,956 $ 93,125 $ 340,843 $ 256,751 Revenue by geography is determined based on the location of our users. Other than the United States, no other individual country accounted for 10% or more of total revenue for any of the periods presented. Unbilled Accounts Receivable Unbilled accounts receivable included in trade accounts receivable, net, which generally arise from our contractual right to bill our customers in advance of services on the contract effective date, were $2.1 million and $1.0 million as of October 31, 2023 and January 31, 2023, respectively. Contract Balances Contract Assets Contract assets as of October 31, 2023 and January 31, 2023 were $0.3 million and $0.8 million, respectively. The change in contract assets for all periods presented primarily reflects revenue recognized in excess of billings partially offset by contract assets earned during the period. Deferred Revenue The change in deferred revenue for all periods presented primarily reflects cash payments received during the period for which the performance obligation was not satisfied prior to the end of the period, partially offset by revenues recognized during the period. Revenue recognized during the three and nine months ended October 31, 2023 from amounts included in deferred revenue at January 31, 2023, was $27.0 million and $155.3 million, re spectively . Revenue recognized during the three and nine months ended October 31, 2022 from amounts included in deferred revenue at January 31, 2022, was $21.3 million and $118.5 million , respectively . Credit Losses The following table presents a reconciliation of the allowance for credit losses on accounts receivable (in thousands): Allowance for Credit Losses Balance at January 31, 2023 $ 1,613 Reserve: Credit losses 1,714 Deferred revenue 2,424 Write-offs (3,014) Recoveries 67 Balance at October 31, 2023 $ 2,804 Remaining Performance Obligations The transaction price allocated to remaining performance obligations represents amounts under non-cancelable contracts expected to be recognized as revenue in future periods, and may be influenced by several factors, including seasonality, the timing of renewals, the timing of service delivery and contract terms. Unbilled portions of the remaining performance obligations are subject to future economic risks including bankruptcies, regulatory changes and other market factors. The following table presents remaining performance obligations as of the dates indicated below (in millions): Total Less than 1 Year 1-5 Years October 31, 2022 $ 408.7 $ 283.3 $ 125.4 January 31, 2023 455.7 312.6 143.1 April 30, 2023 477.5 325.4 152.1 July 31, 2023 523.5 353.3 170.2 October 31, 2023 560.1 369.9 190.2

Variable Interest Entity and Re

Variable Interest Entity and Redeemable Non-Controlling Interest	9 Months Ended
	Oct. 31, 2023
Noncontrolling Interest [Abstract]
Variable Interest Entity and Redeemable Non-Controlling Interest	Variable Interest Entity and Redeemable Non-Controlling Interest On September 14, 2020, we, along with Japan Cloud Computing Co., Ltd., and M30 LLC, (the “Investors”), entered into an agreement, whereby each Investor agreed to purchase shares of common stock of Braze Kabushiki Kaisha (“Braze KK” and “Braze KK Shares”) for a total purchase price of $10.0 million in two tranches of $5.0 million per tranche in September 2020 and September 2021 , to engage in the investment, organization, management and operation of Braze KK focused on the distribution of our products in Japan. The purpose of this arrangement was to further expand our business in the Japanese market. In March 2022, we consented to the periodic issuance of stock options to purchase Braze KK Shares by certain employees of Braze KK. These options cannot be exercised by the holders thereof prior to the exercise of the call or put options described in more detail below. The Company considers the stock options to be a substantive class of equity, classified as a liability within other long-term liabilities on the consolidated balance sheets. As of October 31, 2023, the liability balance was $0.3 million. The issuance of stock options does not impact our majority stake in Braze KK, as none of the vesting criteria of the options were met as of the balance sheet date. The issuance of stock options did not result in a reconsideration event and therefore Braze KK still met the criteria of a Variable Interest Entity as Braze KK did not have sufficient equity at risk to finance their activities. As a result, we continue to operate Braze KK as a subsidiary, exposing us to business and foreign exchange risk. We consolidate Braze KK and present the results within our consolidated balance sheets, consolidated statements of operations, and consolidated statements of cash flows. The common stock held by the Investors is callable by us or puttable by the Investors upon certain contingent events. S hould the call or put option be exercised, the redemption value would be determined based on a prescribed formula derived from the discrete revenues of Braze KK and the Company and may be settled, at our discretion, with our stock or cash. The non-controlling interest in Braze KK is classified in mezzanine equity as redeemable non-controlling interest as a result of the put right available to the Investors in the future, an event that is not solely in our control. The non-controlling interest is not accreted to redemption value because it is currently not probable that the non-controlling interest will become redeemable. The following table summarizes the activity in the redeemable non-controlling interests for the periods indicated below (in thousands): Balance as of January 31, 2023 $ 1,455 Net loss attributable to redeemable non-controlling interest (962) Balance as of October 31, 2023 $ 493

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table sets forth our financial instruments that were measured at fair value on a recurring basis at the periods indicated below, by level within the fair value hierarchy (in thousands): October 31, 2023 Level 1 Level 2 Level 3 Total Financial Assets: Cash equivalents Money market funds $ 20,129 $ — $ — $ 20,129 U.S. government securities 10,343 — — 10,343 Total cash equivalents 30,472 — — 30,472 Marketable securities U.S. government securities $ 316,711 $ — $ — $ 316,711 Foreign securities — 8,292 — 8,292 Corporate debt securities — 82,497 — 82,497 Total marketable securities 316,711 90,789 — 407,500 Liabilities Contingent consideration $ — $ — $ 1,795 $ 1,795 Total liabilities — — 1,795 1,795 Total financial assets $ 347,183 $ 90,789 $ 1,795 $ 439,767 January 31, 2023 Level 1 Level 2 Level 3 Total Financial Assets: Cash equivalents Money market funds $ 30,873 $ — $ — $ 30,873 Total cash equivalents 30,873 — — 30,873 Marketable securities U.S. government securities $ 307,744 $ — $ — $ 307,744 Foreign securities — 2,967 — 2,967 Corporate debt securities — 99,372 — 99,372 Total marketable securities 307,744 102,339 — 410,083 Total financial assets $ 338,617 $ 102,339 $ — $ 440,956 Our money market funds are classified as Level 1 within the fair value hierarchy, because they are valued using quoted prices in active markets as of October 31, 2023 and January 31, 2023. Financial instruments classified as Level 2 within our fair value hierarchy are valued on the basis of prices from an orderly transaction between market participants provided by reputable dealers or pricing services. Prices of these securities are obtained through independent, third-party pricing services and include market quotations that may include both observable and unobservable inputs. In determining the value of a particular investment, pricing services may use certain information with respect to transactions in such investments, quotations from dealers, pricing matrices and market transactions in comparable investments and various relationships between investments. The fair value of our contingent consideration is estimated using Level 3 unobservable inputs. The estimates of fair value are based upon assumptions believed to be reasonable but which are uncertain, and involve significant judgments by management. We will reassess the fair value of the contingent consideration quarterly until the contingency is resolved. The short-term portion of the contingent consideration is recorded within accrued expenses and other current liabilities and the long-term portion is recorded within other-long term liabilities on the consolidated balance sheets. Changes in the fair value are recorded in operating income in the consolidated statements of operations. There were no transfers of financial instruments among Level 1, Level 2 and Level 3 during the periods presented. The following table summarizes the fair value changes in the contingent consideration liability in connection with the acquisition of North Star Y, Pty Ltd (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Beginning fair value $ 1,593 $ — $ — $ — Additions in the period (1) 202 1,795 Ending fair value $ 1,795 $ — $ 1,795 $ — (1) Includes measurement period adjustments related to the Company’s preliminary fair values of the assets acquired and liabilities assumed in business combinations, which did not have a material impact on goodwill.

Marketable Securities

Marketable Securities	9 Months Ended
	Oct. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Marketable Securities Marketable securities consist of the following for the periods presented (in thousands): October 31, 2023 Cost or Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Total Estimated Fair Value U.S. government securities $ 319,866 $ 1 $ (3,156) $ 316,711 Foreign securities 8,337 3 (48) 8,292 Corporate debt securities 83,064 12 (579) 82,497 Total $ 411,267 $ 16 $ (3,783) $ 407,500 January 31, 2023 Cost or Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Total Estimated Fair Value U.S. government securities $ 312,044 $ 31 $ (4,331) $ 307,744 Foreign securities 3,028 — (61) 2,967 Corporate debt securities 100,589 27 (1,244) 99,372 Total $ 415,661 $ 58 $ (5,636) $ 410,083 Accrued interest receivables related to our available-for-sale securities of $3.1 million as of October 31, 2023 and $2.0 million as of January 31, 2023, were included within prepaid expenses and other assets on our consolidated balance sheets. The Company’s short-term investments consist of available-for-sale debt securities and term deposits. The term deposits are at cost, which approximates fair value. The weighted-average remaining maturity of the Company’s investment portfolio was less than one year as of the periods presented. The following table summarizes the fair value and gross unrealized losses aggregated by category of individual securities that have been in a continuous unrealized loss position for greater than 12 months (in thousands): October 31, 2023 Continuous Unrealized Loss for Greater than 12 months Estimated Fair Value Gross Unrealized Losses U.S. government securities $ 111,587 $ (1,200) Foreign securities 3,974 (27) Corporate debt securities 40,557 (358) Total $ 156,118 $ (1,585) No individual security incurred continuous unrealized losses for greater than 12 months as of January 31, 2023. The Company purchases investment grade marketable debt securities which are rated by nationally recognized statistical credit rating organizations in accordance with its investment policy. This policy is designed to minimize the Company's exposure to credit losses. As of October 31, 2023, the credit-quality of the Company’s marketable available-for-sale debt securities had remained stable. The unrealized losses recognized on marketable available-for-sale debt securities as of October 31, 2023 was primarily related to the continued market volatility associated with market expectations of an aggressive pace of interest rate increases by the Federal Reserve. The contractual terms of these investments do not permit the issuer to settle the securities at a price less than the amortized cost basis of the investments and it is not expected that the investments would be settled at a price less than their amortized cost basis. The Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost basis. The Company is not aware of any specific event or circumstance that would require the Company to change its assessment of credit losses for any marketable available-for-sale debt security as of October 31, 2023. These estimates may change, as new events occur and additional information is obtained, and will be recognized on the consolidated financial statements as soon as they become known. No credit losses were recognized as of October 31, 2023 for the Company’s marketable debt securities. The contractual maturities of the investments classified as available-for-sale marketable securities are as follows (in thousands): October 31, 2023 Amortized Cost Estimated Fair Value Due within 1 year $ 211,608 $ 209,384 Due in 1 year through 5 years 199,659 198,116 Total $ 411,267 $ 407,500 January 31, 2023 Amortized Cost Estimated Fair Value Due within 1 year $ 247,214 $ 244,280 Due in 1 year through 5 years 168,447 165,803 Total $ 415,661 $ 410,083 Investment Income Investment income consists of interest income and accretion income/amortization expense on our cash, cash equivalents, restricted cash, and marketable securities. Investment income is included within other income, net on the consolidated statements of operations. The components of investment income were as follows (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Interest income $ 3,532 $ 2,413 $ 9,705 $ 4,812 Amortization of discount/premium, net 588 538 1,579 753 Investment income $ 4,120 $ 2,951 $ 11,284 $ 5,565

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Oct. 31, 2023
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Property and equipment, net, consist of the following (in thousands): October 31, January 31, Capitalized internal-use software $ 11,396 $ 7,344 Computer equipment, office equipment, and software 6,915 8,111 Leasehold improvements 12,841 9,410 Furniture and fixtures 4,093 4,085 Total property and equipment 35,245 28,950 Less: accumulated depreciation and amortization (12,392) (8,611) Total property and equipment, net $ 22,853 $ 20,339 The total depreciation expense and amortization expense for property and equipment was $1.1 million and $1.0 million during the three months ended October 31, 2023 and 2022, respectively and $3.8 million and $2.9 million during the nine months ended October 31, 2023 and 2022, respectively. During the three and nine months ended October 31, 2023, the Company removed $0.6 million and $1.1 million, respectively, of fixed assets consisting of computer equipment, office equipment, and software, that was largely depreciated from property and equipment, gross and accumulated depreciation, which had minimal net impact on the Company’s consolidated financial results. We capitalized internal-use software of $1.5 million and $0.3 million during the three months ended October 31, 2023 and 2022, respectively, and $4.0 million and $1.5 million during the nine months ended October 31, 2023 and 2022, respectively. Amortization for capitalized internal-use software costs recognized within cost of revenue on the consolidated statements of operations was $0.5 million and $0.4 million for the three months ended October 31, 2023 and 2022, respectively, and $1.6 million and $1.3 million during the nine months ended October 31, 2023 and 2022, respectively.

Prepaid Expenses and Other Curr

Prepaid Expenses and Other Current Assets	9 Months Ended
	Oct. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid Expenses and Other Current Assets	Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consist of the following (in thousands): October 31, January 31, Prepaid software subscriptions $ 13,350 $ 12,574 Prepaid advertising 875 833 Prepaid insurance 484 2,795 Investment interest receivable 3,069 2,013 Consumption tax receivable 1,442 1,045 Prepaid events 279 657 Prepaid employee benefits 946 811 Other 3,632 5,435 Total prepaid expenses and other current assets $ 24,077 $ 26,163

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	9 Months Ended
	Oct. 31, 2023
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consists of the following (in thousands): October 31, January 31, Accrued compensation costs $ 15,887 $ 12,644 Accrued software subscriptions 11,943 8,454 Accrued commissions 6,302 6,205 Accrued professional service fees 1,621 1,779 Accrued advertising 1,447 922 Accrued tax liability 7,167 4,188 ESPP payable 2,770 322 Other 2,621 2,901 Total accrued expenses and other current liabilities $ 49,758 $ 37,415

Employee Benefit Plans

Employee Benefit Plans	9 Months Ended
	Oct. 31, 2023
Retirement Benefits [Abstract]
Employee Benefit Plans	Employee Benefit Plans We sponsor a 401(k) defined contribution plan covering all eligible U.S. employees. Contributions to the 401(k) plan are discretionary. Matching contributions under the plan were $0.7 million and $0.9 million for the three months ended October 31, 2023 and 2022, respectively, and $4.3 million and $3.9 million during the nine months ended October 31, 2023 and 2022, respectively.

Stockholder_s Equity (Deficit)

Stockholder’s Equity (Deficit)	9 Months Ended
	Oct. 31, 2023
Equity [Abstract]
Stockholder’s Equity (Deficit)	Stockholder’s Equity Class A and Class B Common Stock We have two classes of common stock, Class A and Class B. The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting, conversion and transfer rights. Each share of Class A common stock is entitled to one vote. Each share of Class B common stock is entitled to ten votes and may be converted at the option of the holder into one share of Class A common stock. In addition, all shares of Class B common stock will automatically convert into shares of Class A common stock in certain circumstances, including on the earlier of (i) the last trading day of the fiscal quarter during which the number of shares of Class B common stock then outstanding represents less than 10% of the aggregate number of shares of Class A common stock and Class B common stock then outstanding, or (ii) the last trading day of the fiscal quarter immediately following the fifth anniversary of our initial public offering. All shares of the Company’s capital stock outstanding immediately prior to our initial public offering, including all shares held by our executive officers, directors and their respective affiliates, and all shares issuable upon the conversion of our then outstanding convertible preferred stock, were reclassified into shares of Class B common stock immediately prior to the completion of the initial public offering. Charitable Contributions In connection with our Pledge 1% commitment, we donated 32,155 shares of our Class A common stock to a charitable donor-advised fund that resulted in the recognition of $1.4 million of expense within general and administrative in our consolidated statements of operations during the three months ended October 31, 2023. There were no donations in the three months ended October 31, 2022. We donated 64,310 and 96,465 shares of our Class A common stock that resulted in the recognition of $2.4 million and $4.3 million of expense within general and administrative in our consolidated statements of operations during the nine months ended October 31, 2023 and 2022, respectively.

Employee Stock Plans

Employee Stock Plans	9 Months Ended
	Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]
Employee Stock Plans	Employee Stock Plans We have historically issued equity awards under our Amended and Restated 2011 Equity Incentive Plan (the “2011 Plan”) and our 2021 Equity Incentive Plan (the “2021 Plan”). Amended and Restated 2011 Equity Incentive Plan Our 2011 Plan provides for the award of stock options and restricted stock units (“RSUs”) to employees, officers, directors, advisors and other service providers of Braze. The terms of each award and the exercise price of awards under the 2011 Plan are determined by our board of directors. Following effectiveness of the 2021 Plan in connection with our initial public offering, no further awards were made under the 2011 Plan. 2021 Equity Incentive Plan In November 2021, our board of directors and our stockholders approved the 2021 Plan, which became effective on November 16, 2021. No grants were made under the 2021 Plan prior to its effectiveness. No further grants will be made under the 2011 Plan. At effectiveness, we reserved 25,660,249 shares of our Class A common stock to be issued under the 2021 Plan. In addition, the number of shares of our Class A common stock reserved for issuance under the 2021 Plan will automatically increase on February 1 of each year for a period of ten years, beginning on February 1, 2022 and continuing through February 1, 2031, in an amount equal to (1) 5% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31, or (2) a lesser number of shares determined by our board of directors no later than the February 1 increase. On February 1, 2023, the number of shares of our Class A common stock reserved for issuance under our 2021 Plan increased by an additional 4,798,771 shares. Restricted Stock Units The following table summarizes unvested RSU award activity and related information: Shares Weighted-Average Grant Date Fair Value Balance as of January 31, 2023 4,625,518 Granted 3,864,954 $ 35.10 Vested (1,189,034) $ 41.73 Forfeited (562,235) $ 37.56 Balance as of October 31, 2023 6,739,203 RSUs granted during the nine months ended October 31, 2023 contained a service-based vesting condition of up to approximately a four-year period. RSUs typically vest on a quarterly basis or have a one year cliff vesting period with quarterly vesting thereafter. Stock-based Compensation Expense The following table summarizes stock-based compensation expense, which was included in the consolidated statements of operations as follows (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Cost of revenue $ 900 $ 889 $ 2,690 $ 2,720 Sales and marketing 7,899 6,512 23,554 17,618 Research and development 9,479 8,060 29,251 21,154 General and administrative 5,761 3,847 17,466 11,900 Stock-based compensation, net of amounts capitalized $ 24,039 $ 19,308 $ 72,961 $ 53,392 Capitalized stock-based compensation expense 582 265 1,516 796 Total stock-based compensation expense $ 24,621 $ 19,573 $ 74,477 $ 54,188 As of October 31, 2023, total compensation cost not yet recognized related to unvested equity awards and the weighted-average remaining period over which these costs are expected to be realized were as follows: Stock Options RSUs Unrecognized compensation costs (in thousands) $32,062 $174,266 Weighted-average remaining recognition period (years) 1.88 2.92 Employee Stock Purchase Plan In November 2021, our board of directors and our stockholders approved the 2021 Employee Stock Purchase Plan (the “ESPP”), which became effective on November 16, 2021. Following completion of our initial public offering, the ESPP authorized the issuance of 1,825,000 shares of our Class A common stock under purchase rights granted to our employees or to employees of any of our designated affiliates. The number of shares of our Class A common stock reserved for issuance will automatically increase on February 1 of each year for a period of ten years, beginning on February 1, 2022 and continuing through February 1, 2031, by the lesser of (i) 1% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31; and (ii) 2,737,000 shares, except before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth in clauses (i) and (ii) above. On February 1, 2023, the number of shares of our Class A common stock reserved for issuance under our ESPP increased by an additional 959,754 shares. The ESPP is implemented through a series of offerings under which eligible employees are granted purchase rights to purchase shares of the Company’s Class A common stock on specified dates during such offerings. Under the ESPP, our board of directors will be permitted to specify offerings with durations of not more than 27 months, and may specify shorter purchase periods within each offering. Each offering will have one or more purchase dates on which shares of our Class A common stock will be purchased for employees participating in the offering. On each purchase date, eligible employees will purchase the shares at a price per share equal to 85% of the lesser of (1) the fair market value of the Company’s Class A common stock on the first trading day of the offering period or (2) the fair market value of the Company’s Class A common stock on the last day of the offering period, as defined by the ESPP. The Company recognized $0.5 million and $0.8 million of stock-based compensation expense related to the ESPP in the three months ended October 31, 2023 and 2022, respectively, and $1.9 million and $1.1 million during the nine months ended October 31, 2023 and 2022, respectively. As of October 31, 2023, $2.8 million has been withheld on behalf of our employees for a future purchase and is classified as accrued expenses and other current liabilities on the consolidated balance sheets.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Indirect Taxes We are subject to indirect taxation in some, but not all, of the various U.S. states and foreign jurisdictions in which we conduct business. Therefore, we have an obligation to charge, collect and remit Value Added Tax (“VAT”) or Goods and Services Tax (“GST”) in connection with certain of our foreign sales transactions and sales and use tax in connection with eligible sales to subscribers in certain U.S. states. On June 21, 2018, the U.S. Supreme Court issued an opinion in South Dakota v. Wayfair. The State of South Dakota alleged that U.S. constitutional law should be revised to permit South Dakota to require remote sellers to collect and remit sales tax in South Dakota in accordance with South Dakota’s sales tax statute. Under the U.S. Supreme Court’s ruling, the longstanding Quill Corp v. North Dakota sales tax case was overruled, and states may now require remote sellers to collect sales tax under certain circumstances. We began collecting sales tax in relevant jurisdictions for the fiscal year ended January 31, 2019. As a result of this ruling and given the scope of our operations, taxing authorities continue to provide regulations that increase the complexity and risks to comply with such laws and could result in substantial liabilities, prospectively as well as retrospectively. Based on the information available, we continue to evaluate and assess the jurisdictions in which indirect tax nexus exists and believe that the indirect tax liabilities are adequate and reasonable. Due to the complexity and uncertainty around the application of these rules by taxing authorities, results may vary materially from expectations, and we have recognized liabilities for contingencies related to state sales and use tax, VAT, and GST deemed probable and estimable totaling $0.8 million and $0.5 million as of October 31, 2023 and January 31, 2023, respectively, which is included in accrued expenses and other current liabilities on the consolidated balance sheets. As of January 31, 2023, we have filed prior period returns in several jurisdictions in order to remediate this potential exposure, and the Company continues to evaluate the potential exposure on an ongoing basis. Legal Contingencies From time to time, in the ordinary course of business, we are or may be involved in various legal or regulatory proceedings, claims or purported class actions related to, among other things, alleged infringement of third-party patents and other intellectual property rights, commercial, labor and employment, wage and hour and other claims. We have been, and may in the future be, put on notice or sued by third parties for alleged infringement of their proprietary rights, including patent infringement. We accrue a liability when we believe that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. We believe we have recorded adequate provisions for any such matters and, as of October 31, 2023, we believe that no material loss will be incurred in excess of the amounts recognized in our financial statements.

Leases

Leases	9 Months Ended
	Oct. 31, 2023
Leases [Abstract]
Leases	Leases The Company’s lease portfolio consists solely of office space with lease terms ranging from approximately one The following table presents information on our operating leases for the three and nine months ended October 31, 2023 and 2022 (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Operating lease cost $ 4,492 $ 3,360 $ 12,005 $ 10,253 Variable lease cost 847 578 2,297 1,838 Short-term lease cost 39 444 424 1,564 Total net lease cost $ 5,378 $ 4,382 $ 14,726 $ 13,655 The future maturities of the Company’s operating lease liabilities by fiscal year were as follows (in thousands): Remainder of 2024 $ 2,537 2025 16,181 2026 15,378 2027 14,414 2028 13,002 Thereafter 63,184 Total future undiscounted lease payments $ 124,696 Less: imputed interest (33,659) Less: tenant improvement allowance not yet received — Total reported lease liability $ 91,037 The Company's lease terms and discount rates are as follows: October 31, Weighted-average remaining lease term (years) 8.1 Weighted-average discount rate 7.1 % Other information for the Company's leases is as follows (in thousands): Nine Months Ended 2023 2022 Cash paid for amounts included in the measurement of lease liabilities $ 9,190 $ 7,199 Operating lease right-of-use assets obtained in exchange for new operating lease liabilities $ 45,267 $ —

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company computes its provision for interim periods by applying an estimated annual effective tax rate to anticipated annual pretax income or loss as directed by ASC 740. The estimated annual effective tax rate is applied to the Company’s year to date income or loss, and is adjusted for discrete items recorded in the period. The Company recorded an income tax expense (benefit) of $0.4 million and $(0.4) million for the three months ended October 31, 2023 and 2022, respectively. The effective tax rate for the three months ended October 31, 2023 and 2022 was (1.3)% and 1.1%, respectively. The Company recorded an income tax expense (benefit) of $1.3 million and $(0.3) million for the nine months ended October 31, 2023 and 2022, respectively. The effective tax rate for the nine months ended October 31, 2023 and 2022 was (1.3)% and 0.3%, respectively. The provision for income taxes recorded for the three and nine months ended October 31, 2023 consists of income taxes in state jurisdictions and foreign jurisdictions in which the Company conducts business. The primary difference between the effective tax rate and the statutory rate is the change in the valuation allowance recorded. The Company continues to maintain a full valuation allowance against its net deferred tax assets as we have concluded that it is not more likely than not that the deferred tax assets will be realized. When the Company determines that it will be able to realize some portion or all of its deferred tax assets, an adjustment to its valuation allowance on its deferred tax assets would have the effect of increasing net income in the period such determination is made.

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Oct. 31, 2023
Earnings Per Share [Abstract]
Net Loss per Share	Net Loss per Share We compute net loss per share of Class A common stock and Class B common stock under the two-class method required for multiple classes of common stock and participating securities. The rights, including the liquidation and dividend rights, of the Class A common stock and Class B common stock are substantially identical, other than voting rights. Accordingly, the Class A common stock and Class B common stock share in the Company’s net loss. The following table sets forth the computation of basic and diluted net loss per share attributable to Braze, Inc. common shareholders during the periods presented (in thousands, except per share amounts): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Numerator: Net loss attributable to Braze, Inc. $ (30,741) $ (33,360) $ (100,889) $ (105,515) Denominator: Weighted-average shares of Braze, Inc. common stock outstanding 97,880 94,492 97,619 94,201 Less: weighted-average unvested shares of Braze, Inc. subject to repurchase — (23) (4) (33) Weighted-average shares used to calculate net loss per share attributable to Braze, Inc. common stockholders, basic and diluted 97,880 94,469 97,615 94,168 Net loss per share attributable to Braze, Inc. common stockholders, basic and diluted $ (0.31) $ (0.35) $ (1.03) $ (1.12) The following outstanding shares of potentially dilutive securities have been excluded from diluted net loss per share attributable to Braze, Inc. common shareholders for the periods presented, because their inclusion would be anti-dilutive (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Options to purchase common stock 6,419 8,681 6,419 8,681 Restricted stock units 6,739 3,727 6,739 3,727 ESPP shares estimated to be purchased 109 18 109 114 Total 13,267 12,426 13,267 12,522

Related Party Transactions

Related Party Transactions	9 Months Ended
	Oct. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions In May 2021, the Chief Financial Officer of Datadog, Inc., one of our vendors, joined our board of directors. We have purchased services from Datadog, Inc. in the aggregate amount of approxi mately $0.4 million and $0.0 million during the three months ended October 31, 2023 and 2022, respectively, and $1.6 million and $1.0 million duri ng the nine months ended October 31, 2023 and 2022, respectively .

Restructuring

Restructuring	9 Months Ended
	Oct. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring In May 2023, the Company implemented a workforce reduction designed to rebalance talent to better meet customer needs and achieve business priorities. As a result, the Company recorded associated severance and other termination costs of approximately $0.0 million and $0.6 million in the three months ended October 31, 2023 and nine months ended October 31, 2023, respectively, related to these measures. No restructuring costs were recognized during the three and nine months ended October 31, 2022.

Business Combination

Business Combination	9 Months Ended
	Oct. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combination	Business Combination Acquisition of North Star Y, Pty Ltd On June 1, 2023, the Company acquired all the outstanding stock of North Star Y, Pty Ltd (“North Star”), Braze’s exclusive reseller in Australia and New Zealand. The transaction provides Braze with a direct market presence in Australia and New Zealand, along with local market expertise from the North Star team. The total purchase price consideration, as adjusted, of $28.4 million consisted of cash payments of $17.6 million, $6.1 million in issuances of Braze Class A common stock, and contingent consideration payments, the fair value of which is $1.8 million as of the acquisition date. The sellers are eligible to receive cash earn out payments calculated based on qualified revenue performance metrics for the two individual twelve month periods immediately subsequent to the closing of the acquisition. The earn out payments are capped at $10.0 million for the first earn out period and $16.0 million for second earn out period. The preliminary purchase price, as adjusted, was allocated to intangible assets in the amount of $3.8 million and goodwill in the amount of $28.1 million based on the respective estimated fair values. The resulting goodwill is not deductible for income tax purposes. An indemnification holdback of $2.8 million was recorded within other long-term liabilities on the consolidated balance sheets. The indemnification holdback represents security for potential indemnification claims against the seller. The indemnification holdback will be released subject to amounts withheld for actual, pending or potential claims. Of the initial $0.5 million working capital holdback, $0.2 million has been released based on the completion of post-close adjustment procedures. The results of operations of North Star from the date of acquisition, which were not material, have been included in the Company’s consolidated statements of operations for the nine months ended October 31, 2023.

Intangible Assets, Net

Intangible Assets, Net	9 Months Ended
	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net	Intangible Assets, Net Intangible assets, net, consisted of the following (in thousands): October 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Amortization Period Amortizable intangible assets Customer relationships $ 3,119 $ (130) $ 2,989 10 years Restrictive covenant relationships 186 (39) 147 2 years Trademark 465 (194) 271 1 year Total amortizable intangible assets 3,770 (363) 3,407 Non-amortizable intangible assets Technology licenses 500 — 500 n/a Total intangible assets, net $ 4,270 $ (363) $ 3,907 January 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Amortization Period Non-amortizable intangible assets Technology licenses $ 500 $ — $ 500 n/a Total intangible assets, net $ 500 $ — $ 500 Intangible amortization expense was approximately $0.2 million and $0.4 million for the three and nine months ended October 31, 2023, respectively. There was no intangible amortization expense for the three and nine months ended October 31, 2022. As of October 31, 2023, future amortization expense by fiscal year is expected to be as follows (in thousands): Amount Remainder of 2024 $ 217 2025 560 2026 343 2027 312 2028 312 Thereafter 1,663 Total $ 3,407

Goodwill

Goodwill	9 Months Ended
	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill The changes in the carrying amounts of goodwill were as follows (in thousands): Amount Balance at January 31, 2023 $ — North Star addition and related adjustments (1) 28,112 Balance at October 31, 2023 $ 28,112 (1) Includes measurement period adjustments related to the Company’s preliminary fair values of the assets acquired and liabilities assumed in business combinations, which did not have a material impact on goodwill.

Subsequent Events

Subsequent Events	9 Months Ended
	Oct. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, and variable interest entities (“VIE”) for which we are the primary beneficiary. Intercompany balances and transactions have been eliminated in consolidation.
Reclassifications	Reclassifications Certain reclassifications and immaterial changes have been made to prior-period financial statements to conform to the current-period presentation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reported period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Significant items subject to such estimates and assumptions include, but are not limited to, the standalone selling price for separate performance obligations in our revenue arrangements, expected period of benefit for deferred contract costs, the valuation of common stock and stock-based compensation, the allocation of overhead costs between cost of revenue and operating expenses, the estimated useful lives of intangible and depreciable assets, the fair value of acquired assets and assumed liabilities from business combinations, valuation of long-lived assets and their recoverability, including goodwill, the incremental borrowing rate, the valuation of deferred tax assets and liabilities and other tax estimates including our ability to utilize net operating losses.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents, restricted cash, marketable securities, and accounts receivable. Restricted cash consists of letters of credit related to our leased properties. For cash, cash equivalents, restricted cash, and marketable securities, we are exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the consolidated balance sheets in excess of the Federal Deposit Insurance Corporation (“FDIC”) limits. Cash, cash equivalents, restricted cash, and marketable securities balances are maintained at financial institutions that management believes are of high-credit, quality financial institutions, where deposits, at times, exceed the FDIC limits. Significant customers are those which represent 10% or more of our total revenue for the period, or accounts receivable at the balance sheets dates. For the three and nine months ended October 31, 2023 and October 31, 2022, no customer accounted for 10% or more of our total revenue. For accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the consolidated balance sheets. As of October 31, 2023 and January 31, 2023, no customers accounted for 10% or more of our total accounts receivable balance.
Business Combinations	Business Combinations
Goodwill and Indefinite-Lived Intangible Assets	Goodwill and Indefinite-Lived Intangible Assets Goodwill represents the excess of the aggregate purchase price over the fair value of net identifiable assets acquired in a business combination. Goodwill and indefinite-lived intangible assets are not amortized and are tested for impairment at least annually or whenever events or changes in circumstances indicate that the carrying value may be impaired. Goodwill is tested for impairment at the reporting unit level. The Company has the option to first perform a qualitative assessment to determine if it is more likely than not that the fair value of a reporting unit and indefinite-lived intangible assets are less than its carrying amount. The Company may elect to bypass the qualitative assessment and proceed directly to the quantitative impairment tests. The quantitative impairment test for goodwill involves comparing the fair value of the reporting unit to its carrying value, including goodwill. A goodwill impairment will be the amount by which a reporting unit’s carrying value exceeds its fair value. The impairment is limited to the carrying amount of goodwill. The quantitative impairment test for indefinite-lived intangible assets involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the indefinite-lived intangible asset exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. The estimates of fair value of indefinite-lived intangible assets are determined using a discounted cash flow valuation analysis that employs different valuation methodology in estimating the fair value of the asset. Significant judgments are inherent in the discounted cash flow analysis. The Company has determined that it operates as one reporting unit and has selected November 1 as the date to perform its annual impairment test. No goodwill impairment charges have been recorded for any period presented.
Recently Adopted Accounting Pronouncements	Recent Accounting Pronouncements In October 2021, the Financial Accounting Standards Board issued Accounting Standards Update No. 2021-08 Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, (“ASU 2021-08”), which requires that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. The Company adopted ASU 2021-08 prospectively during the second quarter of the fiscal year ended January 31, 2024, and determined that ASU 2021-08 does not have a material impact on the Company’s consolidated financial statements nor its related disclosures. The Company has implemented all applicable accounting pronouncements that are in effect and there are no new accounting pronouncements that have been issued that would have a material impact on the Company's condensed consolidated financial statements.

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	9 Months Ended
	Oct. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table presents total revenue by type (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Subscription $ 118,345 $ 88,982 $ 325,202 $ 243,545 Professional services and other 5,611 4,143 15,641 13,206 Total $ 123,956 $ 93,125 $ 340,843 $ 256,751
Schedule of Total Revenue by Geography	The following table presents total revenue by geography (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 United States $ 69,724 $ 53,259 $ 193,341 $ 148,486 International 54,232 39,866 147,502 108,265 Total $ 123,956 $ 93,125 $ 340,843 $ 256,751
Schedule of Allowance for Credit Loss Rollforward	The following table presents a reconciliation of the allowance for credit losses on accounts receivable (in thousands): Allowance for Credit Losses Balance at January 31, 2023 $ 1,613 Reserve: Credit losses 1,714 Deferred revenue 2,424 Write-offs (3,014) Recoveries 67 Balance at October 31, 2023 $ 2,804
Schedule of Remaining Performance Obligations	The following table presents remaining performance obligations as of the dates indicated below (in millions): Total Less than 1 Year 1-5 Years October 31, 2022 $ 408.7 $ 283.3 $ 125.4 January 31, 2023 455.7 312.6 143.1 April 30, 2023 477.5 325.4 152.1 July 31, 2023 523.5 353.3 170.2 October 31, 2023 560.1 369.9 190.2

Variable Interest Entity and _2

Variable Interest Entity and Redeemable Non-Controlling Interest (Tables)	9 Months Ended
	Oct. 31, 2023
Noncontrolling Interest [Abstract]
Schedule of Redeemable Noncontrolling Interest	The following table summarizes the activity in the redeemable non-controlling interests for the periods indicated below (in thousands): Balance as of January 31, 2023 $ 1,455 Net loss attributable to redeemable non-controlling interest (962) Balance as of October 31, 2023 $ 493

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Financial Instruments Measured at Fair Value on a Recurring Basis	The following table sets forth our financial instruments that were measured at fair value on a recurring basis at the periods indicated below, by level within the fair value hierarchy (in thousands): October 31, 2023 Level 1 Level 2 Level 3 Total Financial Assets: Cash equivalents Money market funds $ 20,129 $ — $ — $ 20,129 U.S. government securities 10,343 — — 10,343 Total cash equivalents 30,472 — — 30,472 Marketable securities U.S. government securities $ 316,711 $ — $ — $ 316,711 Foreign securities — 8,292 — 8,292 Corporate debt securities — 82,497 — 82,497 Total marketable securities 316,711 90,789 — 407,500 Liabilities Contingent consideration $ — $ — $ 1,795 $ 1,795 Total liabilities — — 1,795 1,795 Total financial assets $ 347,183 $ 90,789 $ 1,795 $ 439,767 January 31, 2023 Level 1 Level 2 Level 3 Total Financial Assets: Cash equivalents Money market funds $ 30,873 $ — $ — $ 30,873 Total cash equivalents 30,873 — — 30,873 Marketable securities U.S. government securities $ 307,744 $ — $ — $ 307,744 Foreign securities — 2,967 — 2,967 Corporate debt securities — 99,372 — 99,372 Total marketable securities 307,744 102,339 — 410,083 Total financial assets $ 338,617 $ 102,339 $ — $ 440,956
Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis	The following table summarizes the fair value changes in the contingent consideration liability in connection with the acquisition of North Star Y, Pty Ltd (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Beginning fair value $ 1,593 $ — $ — $ — Additions in the period (1) 202 1,795 Ending fair value $ 1,795 $ — $ 1,795 $ — (1) Includes measurement period adjustments related to the Company’s preliminary fair values of the assets acquired and liabilities assumed in business combinations, which did not have a material impact on goodwill.

Marketable Securities (Tables)

Marketable Securities (Tables)	9 Months Ended
	Oct. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Components of Marketable Securities	Marketable securities consist of the following for the periods presented (in thousands): October 31, 2023 Cost or Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Total Estimated Fair Value U.S. government securities $ 319,866 $ 1 $ (3,156) $ 316,711 Foreign securities 8,337 3 (48) 8,292 Corporate debt securities 83,064 12 (579) 82,497 Total $ 411,267 $ 16 $ (3,783) $ 407,500 January 31, 2023 Cost or Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Total Estimated Fair Value U.S. government securities $ 312,044 $ 31 $ (4,331) $ 307,744 Foreign securities 3,028 — (61) 2,967 Corporate debt securities 100,589 27 (1,244) 99,372 Total $ 415,661 $ 58 $ (5,636) $ 410,083
Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value	The following table summarizes the fair value and gross unrealized losses aggregated by category of individual securities that have been in a continuous unrealized loss position for greater than 12 months (in thousands): October 31, 2023 Continuous Unrealized Loss for Greater than 12 months Estimated Fair Value Gross Unrealized Losses U.S. government securities $ 111,587 $ (1,200) Foreign securities 3,974 (27) Corporate debt securities 40,557 (358) Total $ 156,118 $ (1,585)
Schedule of Marketable Securities by Contractual Maturity	The contractual maturities of the investments classified as available-for-sale marketable securities are as follows (in thousands): October 31, 2023 Amortized Cost Estimated Fair Value Due within 1 year $ 211,608 $ 209,384 Due in 1 year through 5 years 199,659 198,116 Total $ 411,267 $ 407,500 January 31, 2023 Amortized Cost Estimated Fair Value Due within 1 year $ 247,214 $ 244,280 Due in 1 year through 5 years 168,447 165,803 Total $ 415,661 $ 410,083
Schedule of Investment Income	Investment income consists of interest income and accretion income/amortization expense on our cash, cash equivalents, restricted cash, and marketable securities. Investment income is included within other income, net on the consolidated statements of operations. The components of investment income were as follows (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Interest income $ 3,532 $ 2,413 $ 9,705 $ 4,812 Amortization of discount/premium, net 588 538 1,579 753 Investment income $ 4,120 $ 2,951 $ 11,284 $ 5,565

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Oct. 31, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property and equipment, net	Property and equipment, net, consist of the following (in thousands): October 31, January 31, Capitalized internal-use software $ 11,396 $ 7,344 Computer equipment, office equipment, and software 6,915 8,111 Leasehold improvements 12,841 9,410 Furniture and fixtures 4,093 4,085 Total property and equipment 35,245 28,950 Less: accumulated depreciation and amortization (12,392) (8,611) Total property and equipment, net $ 22,853 $ 20,339

Prepaid Expenses and Other Cu_2

Prepaid Expenses and Other Current Assets (Tables)	9 Months Ended
	Oct. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consist of the following (in thousands): October 31, January 31, Prepaid software subscriptions $ 13,350 $ 12,574 Prepaid advertising 875 833 Prepaid insurance 484 2,795 Investment interest receivable 3,069 2,013 Consumption tax receivable 1,442 1,045 Prepaid events 279 657 Prepaid employee benefits 946 811 Other 3,632 5,435 Total prepaid expenses and other current assets $ 24,077 $ 26,163

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Oct. 31, 2023
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consists of the following (in thousands): October 31, January 31, Accrued compensation costs $ 15,887 $ 12,644 Accrued software subscriptions 11,943 8,454 Accrued commissions 6,302 6,205 Accrued professional service fees 1,621 1,779 Accrued advertising 1,447 922 Accrued tax liability 7,167 4,188 ESPP payable 2,770 322 Other 2,621 2,901 Total accrued expenses and other current liabilities $ 49,758 $ 37,415

Employee Stock Plans (Tables)

Employee Stock Plans (Tables)	9 Months Ended
	Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Summarized Unvested RSU Award Activity	The following table summarizes unvested RSU award activity and related information: Shares Weighted-Average Grant Date Fair Value Balance as of January 31, 2023 4,625,518 Granted 3,864,954 $ 35.10 Vested (1,189,034) $ 41.73 Forfeited (562,235) $ 37.56 Balance as of October 31, 2023 6,739,203
Schedule of Stock-Based Compensation Expense	The following table summarizes stock-based compensation expense, which was included in the consolidated statements of operations as follows (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Cost of revenue $ 900 $ 889 $ 2,690 $ 2,720 Sales and marketing 7,899 6,512 23,554 17,618 Research and development 9,479 8,060 29,251 21,154 General and administrative 5,761 3,847 17,466 11,900 Stock-based compensation, net of amounts capitalized $ 24,039 $ 19,308 $ 72,961 $ 53,392 Capitalized stock-based compensation expense 582 265 1,516 796 Total stock-based compensation expense $ 24,621 $ 19,573 $ 74,477 $ 54,188
Schedule of Compensation Cost Not Yet Recognized	As of October 31, 2023, total compensation cost not yet recognized related to unvested equity awards and the weighted-average remaining period over which these costs are expected to be realized were as follows: Stock Options RSUs Unrecognized compensation costs (in thousands) $32,062 $174,266 Weighted-average remaining recognition period (years) 1.88 2.92

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 31, 2023
Leases [Abstract]
Schedule of Lease Cost, Terms, Discount Rates and Other Information	The following table presents information on our operating leases for the three and nine months ended October 31, 2023 and 2022 (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Operating lease cost $ 4,492 $ 3,360 $ 12,005 $ 10,253 Variable lease cost 847 578 2,297 1,838 Short-term lease cost 39 444 424 1,564 Total net lease cost $ 5,378 $ 4,382 $ 14,726 $ 13,655 The Company's lease terms and discount rates are as follows: October 31, Weighted-average remaining lease term (years) 8.1 Weighted-average discount rate 7.1 % Other information for the Company's leases is as follows (in thousands): Nine Months Ended 2023 2022 Cash paid for amounts included in the measurement of lease liabilities $ 9,190 $ 7,199 Operating lease right-of-use assets obtained in exchange for new operating lease liabilities $ 45,267 $ —
Schedule of Maturities of Operating Lease Liabilities	The future maturities of the Company’s operating lease liabilities by fiscal year were as follows (in thousands): Remainder of 2024 $ 2,537 2025 16,181 2026 15,378 2027 14,414 2028 13,002 Thereafter 63,184 Total future undiscounted lease payments $ 124,696 Less: imputed interest (33,659) Less: tenant improvement allowance not yet received — Total reported lease liability $ 91,037

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Oct. 31, 2023
Earnings Per Share [Abstract]
Schedule of Net Loss Per Share	The following table sets forth the computation of basic and diluted net loss per share attributable to Braze, Inc. common shareholders during the periods presented (in thousands, except per share amounts): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Numerator: Net loss attributable to Braze, Inc. $ (30,741) $ (33,360) $ (100,889) $ (105,515) Denominator: Weighted-average shares of Braze, Inc. common stock outstanding 97,880 94,492 97,619 94,201 Less: weighted-average unvested shares of Braze, Inc. subject to repurchase — (23) (4) (33) Weighted-average shares used to calculate net loss per share attributable to Braze, Inc. common stockholders, basic and diluted 97,880 94,469 97,615 94,168 Net loss per share attributable to Braze, Inc. common stockholders, basic and diluted $ (0.31) $ (0.35) $ (1.03) $ (1.12)
Schedule of Potentially Diluted Securities	The following outstanding shares of potentially dilutive securities have been excluded from diluted net loss per share attributable to Braze, Inc. common shareholders for the periods presented, because their inclusion would be anti-dilutive (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Options to purchase common stock 6,419 8,681 6,419 8,681 Restricted stock units 6,739 3,727 6,739 3,727 ESPP shares estimated to be purchased 109 18 109 114 Total 13,267 12,426 13,267 12,522

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	9 Months Ended
	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets and Goodwill	Intangible assets, net, consisted of the following (in thousands): October 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Amortization Period Amortizable intangible assets Customer relationships $ 3,119 $ (130) $ 2,989 10 years Restrictive covenant relationships 186 (39) 147 2 years Trademark 465 (194) 271 1 year Total amortizable intangible assets 3,770 (363) 3,407 Non-amortizable intangible assets Technology licenses 500 — 500 n/a Total intangible assets, net $ 4,270 $ (363) $ 3,907 January 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Amortization Period Non-amortizable intangible assets Technology licenses $ 500 $ — $ 500 n/a Total intangible assets, net $ 500 $ — $ 500
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of October 31, 2023, future amortization expense by fiscal year is expected to be as follows (in thousands): Amount Remainder of 2024 $ 217 2025 560 2026 343 2027 312 2028 312 Thereafter 1,663 Total $ 3,407

Goodwill (Tables)

Goodwill (Tables)	9 Months Ended
	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amounts of goodwill were as follows (in thousands): Amount Balance at January 31, 2023 $ — North Star addition and related adjustments (1) 28,112 Balance at October 31, 2023 $ 28,112 (1) Includes measurement period adjustments related to the Company’s preliminary fair values of the assets acquired and liabilities assumed in business combinations, which did not have a material impact on goodwill.

Revenue from Contracts with C_3

Revenue from Contracts with Customers - Disaggregation of Revenue by Type (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 123,956	$ 93,125	$ 340,843	$ 256,751
Subscription
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	118,345	88,982	325,202	243,545
Professional services and other
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 5,611	$ 4,143	$ 15,641	$ 13,206

Revenue from Contracts with C_4

Revenue from Contracts with Customers - Disaggregation of Revenue by Geography (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 123,956	$ 93,125	$ 340,843	$ 256,751
United States
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	69,724	53,259	193,341	148,486
International
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 54,232	$ 39,866	$ 147,502	$ 108,265

Revenue from Contracts with C_5

Revenue from Contracts with Customers - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023
Revenue from Contract with Customer [Abstract]
Unbilled receivables	$ 2.1		$ 2.1		$ 1
Contract asset	0.3		0.3		$ 0.8
Revenue recognized from previously recorded contract liabilities	$ 27	$ 21.3	$ 155.3	$ 118.5

Revenue from Contracts with C_6

Revenue from Contracts with Customers - Allowance for Credit Loss Rollforward (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2023 USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	$ 1,613
Credit losses	1,714
Deferred revenue	2,424
Write-offs	(3,014)
Recoveries	67
Ending balance	$ 2,804

Revenue from Contracts with C_7

Revenue from Contracts with Customers - Remaining Performance Obligations (Details) - USD ($) $ in Millions	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Jan. 31, 2023	Oct. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 560.1	$ 523.5	$ 477.5	$ 455.7	$ 408.7
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-08-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount					283.3
Revenue, remaining performance obligation, period				1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount				$ 312.6
Revenue, remaining performance obligation, period			1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount			$ 325.4
Revenue, remaining performance obligation, period				1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-05-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount		353.3
Revenue, remaining performance obligation, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-08-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 369.9				$ 125.4
Revenue, remaining performance obligation, period				4 years	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount				$ 143.1
Revenue, remaining performance obligation, period			4 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount			$ 152.1
Revenue, remaining performance obligation, period				4 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-05-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount		$ 170.2
Revenue, remaining performance obligation, period	4 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-08-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 190.2
Revenue, remaining performance obligation, period					4 years

Variable Interest Entity and _3

Variable Interest Entity and Redeemable Non-Controlling Interest - Narrative (Details) - USD ($) $ in Millions	1 Months Ended		13 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Oct. 31, 2023
Noncontrolling Interest [Line Items]
Other long-term liability, deferred compensation				$ 0.3
Braze KK
Noncontrolling Interest [Line Items]
Consideration received	$ 5	$ 5	$ 10

Variable Interest Entity and _4

Variable Interest Entity and Redeemable Non-Controlling Interest - Redeemable Noncontrolling Interest (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Noncontrolling Interest [Roll Forward]
Beginning balance	$ 728	$ 2,344	$ 1,455	$ 3,235
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest	(235)	(532)	(962)	(1,423)
Ending balance	$ 493	$ 1,812	$ 493	$ 1,812

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 30,472	$ 30,873
Marketable securities	407,500	410,083
Contingent consideration	1,795
Total liabilities	1,795
Total financial assets	439,767	440,956
U.S. government securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	316,711	307,744
Foreign securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	8,292	2,967
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	82,497	99,372
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	20,129	30,873
U.S. government securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	10,343
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	30,472	30,873
Marketable securities	316,711	307,744
Contingent consideration	0
Total liabilities	0
Total financial assets	347,183	338,617
Level 1 | U.S. government securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	316,711	307,744
Level 1 | Foreign securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Level 1 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	20,129	30,873
Level 1 | U.S. government securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	10,343
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Marketable securities	90,789	102,339
Contingent consideration	0
Total liabilities	0
Total financial assets	90,789	102,339
Level 2 | U.S. government securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Level 2 | Foreign securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	8,292	2,967
Level 2 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	82,497	99,372
Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Level 2 | U.S. government securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Marketable securities	0	0
Contingent consideration	1,795
Total liabilities	1,795
Total financial assets	1,795	0
Level 3 | U.S. government securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Level 3 | Foreign securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Level 3 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Level 3 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	$ 0
Level 3 | U.S. government securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 0

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Changes in Fair Value Liability (Details) - Contingent Consideration Liability - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning fair value	$ 1,593	$ 0	$ 0	$ 0
Additions in the period	202		1,795
Ending fair value	$ 1,795	$ 0	$ 1,795	$ 0

Marketable Securities - Compone

Marketable Securities - Components of Marketable Securities (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Debt Securities, Available-for-sale [Line Items]
Cost or Amortized Cost	$ 411,267	$ 415,661
Gross Unrealized Gains	16	58
Gross Unrealized Losses	(3,783)	(5,636)
Total Estimated Fair Value	407,500	410,083
U.S. government securities
Debt Securities, Available-for-sale [Line Items]
Cost or Amortized Cost	319,866	312,044
Gross Unrealized Gains	1	31
Gross Unrealized Losses	(3,156)	(4,331)
Total Estimated Fair Value	316,711	307,744
Foreign securities
Debt Securities, Available-for-sale [Line Items]
Cost or Amortized Cost	8,337	3,028
Gross Unrealized Gains	3	0
Gross Unrealized Losses	(48)	(61)
Total Estimated Fair Value	8,292	2,967
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Cost or Amortized Cost	83,064	100,589
Gross Unrealized Gains	12	27
Gross Unrealized Losses	(579)	(1,244)
Total Estimated Fair Value	$ 82,497	$ 99,372

Marketable Securities - Narrati

Marketable Securities - Narrative (Details) - USD ($)	Oct. 31, 2023	Jan. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Accrued interest receivable	$ 3,100,000	$ 2,000,000
Allowance for credit loss	$ 0

Marketable Securities - Continu

Marketable Securities - Continuous Loss Position (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Debt Securities, Available-for-sale [Line Items]
Estimated Fair Value	$ 156,118
Gross Unrealized Losses	(1,585)
U.S. government securities
Debt Securities, Available-for-sale [Line Items]
Estimated Fair Value	111,587
Gross Unrealized Losses	(1,200)
Foreign securities
Debt Securities, Available-for-sale [Line Items]
Estimated Fair Value	3,974
Gross Unrealized Losses	(27)
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Estimated Fair Value	40,557
Gross Unrealized Losses	$ (358)

Marketable Securities - Contrac

Marketable Securities - Contractual Maturity (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Amortized Cost
Due within 1 year	$ 211,608	$ 247,214
Due in 1 year through 5 years	199,659	168,447
Cost or Amortized Cost	411,267	415,661
Estimated Fair Value
Due within 1 year	209,384	244,280
Due in 1 year through 5 years	198,116	165,803
Total Estimated Fair Value	$ 407,500	$ 410,083

Marketable Securities - Investm

Marketable Securities - Investment Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Interest income	$ 3,532	$ 2,413	$ 9,705	$ 4,812
Amortization of discount/premium, net	588	538	1,579	753
Investment income	$ 4,120	$ 2,951	$ 11,284	$ 5,565

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 35,245		$ 35,245		$ 28,950
Less: accumulated depreciation and amortization	(12,392)		(12,392)		(8,611)
Total property and equipment, net	22,853		22,853		20,339
Depreciation and amortization expense	1,100	$ 1,000	3,800	$ 2,900
Capitalized internal-use software	1,500	300	4,000	1,500
Removal of fixed assets	600		1,100
Cost of revenue
Property, Plant and Equipment [Line Items]
Amortization for capital internal-use software	(500)	$ (400)	(1,600)	$ (1,300)
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	11,396		11,396		7,344
Computer equipment, office equipment, and software
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	6,915		6,915		8,111
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	12,841		12,841		9,410
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 4,093		$ 4,093		$ 4,085

Prepaid Expenses and Other Cu_3

Prepaid Expenses and Other Current Assets - Summary (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid software subscriptions	$ 13,350	$ 12,574
Prepaid advertising	875	833
Prepaid insurance	484	2,795
Investment interest receivable	3,069	2,013
Consumption tax receivable	1,442	1,045
Prepaid events	279	657
Prepaid employee benefits	946	811
Other	3,632	5,435
Total prepaid expenses and other current assets	$ 24,077	$ 26,163

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Payables and Accruals [Abstract]
Accrued compensation costs	$ 15,887	$ 12,644
Accrued software subscriptions	11,943	8,454
Accrued commissions	6,302	6,205
Accrued professional service fees	1,621	1,779
Accrued advertising	1,447	922
Accrued tax liability	7,167	4,188
ESPP payable	2,770	322
Other	2,621	2,901
Total accrued expenses and other current liabilities	$ 49,758	$ 37,415

Employee Benefit Plans (Details

Employee Benefit Plans (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Retirement Benefits [Abstract]
Contributions	$ 0.7	$ 0.9	$ 4.3	$ 3.9

Stockholder_s Equity (Deficit)

Stockholder’s Equity (Deficit) (Details) $ in Millions	3 Months Ended	9 Months Ended
	Oct. 31, 2023 USD ($) vote class shares	Oct. 31, 2023 USD ($) vote class shares	Oct. 31, 2022 USD ($) shares
Class of Stock [Line Items]
Classes of common stock (in classes) | class	2	2
Threshold for conversion	10%	10%
Charitable donation | $	$ 1.4	$ 2.4	$ 4.3
Class A common stock
Class of Stock [Line Items]
Votes per share (in votes)	1	1
Common stock converted (in votes)	1	1
Charitable donation (in shares) | shares	32,155	64,310	96,465
Class B common stock
Class of Stock [Line Items]
Votes per share (in votes)	10	10

Employee Stock Plans - Narrativ

Employee Stock Plans - Narrative (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended		9 Months Ended
	Feb. 01, 2023	Nov. 30, 2021	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Nov. 16, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation, net of amounts capitalized			$ 24,039	$ 19,308	$ 72,961	$ 53,392
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award cliff vesting period					4 years
RSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award cliff vesting period					1 year
2021 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares reserved for future issuance (in shares)		25,660,249
Shares reserved for future issuance, period of automatic increase		10 years
Shares reserved for future issuance, increase as percentage of total shares outstanding		5%
Shares reserved for future issuance, additional shares reserved (in shares)	4,798,771
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance, period of automatic increase		10 years
Shares reserved for future issuance, increase as percentage of total shares outstanding		1%
Shares reserved for future issuance, additional shares reserved (in shares)	959,754
Automatic increase in ESPP (in shares)							2,737,000
Employee Stock Purchase Plan | Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares reserved for issuance (in shares)							1,825,000
Stock-based compensation, net of amounts capitalized			500	$ 800	$ 1,900	$ 1,100
Share-based compensation amount withheld from employees for future purchase			$ 2,800		$ 2,800
Number available for grant (in share)			3,461,054		3,461,054

Employee Stock Plans - Schedule

Employee Stock Plans - Schedule of Summarized Unvested RSU Award Activity (Details) - RSUs	9 Months Ended
	Oct. 31, 2023 $ / shares shares
Stock units
Beginning balance, outstanding (in shares) | shares	4,625,518
Granted (in shares) | shares	3,864,954
Vested (in shares) | shares	(1,189,034)
Forfeited (in shares) | shares	(562,235)
Ending balance, outstanding (in shares) | shares	6,739,203
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares
Granted (in dollars per share) | $ / shares	35.10
Vested (in dollars per share) | $ / shares	41.73
Forfeited (in dollars per share) | $ / shares	37.56
Ending balance (in dollars per share) | $ / shares

Employee Stock Plans - Stock-Ba

Employee Stock Plans - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	$ 24,039	$ 19,308	$ 72,961	$ 53,392
Capitalized stock-based compensation expense	582	265	1,516	796
Total stock-based compensation expense	24,621	19,573	74,477	54,188
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	900	889	2,690	2,720
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	7,899	6,512	23,554	17,618
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	9,479	8,060	29,251	21,154
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	$ 5,761	$ 3,847	$ 17,466	$ 11,900

Employee Stock Plans - Compensa

Employee Stock Plans - Compensation Cost Not Yet Recognized (Details)	9 Months Ended
	Oct. 31, 2023 USD ($)
Stock Options
Share-Based Payment Arrangement [Abstract]
Weighted-average remaining recognition period (years)	1 year 10 months 17 days
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs (in thousands)	$ 32,062,000
Weighted-average remaining recognition period (years)	1 year 10 months 17 days
RSUs
Share-Based Payment Arrangement [Abstract]
Unrecognized compensation costs (in thousands)	$ 174,266,000
Weighted-average remaining recognition period (years)	2 years 11 months 1 day
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs (in thousands)	$ 174,266,000
Weighted-average remaining recognition period (years)	2 years 11 months 1 day

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	Oct. 31, 2023	Jan. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Taxes payable	$ 0.8	$ 0.5

Leases - Narrative (Details)

Leases - Narrative (Details)	Oct. 31, 2023
Minimum
Lessee, Lease, Description [Line Items]
Term of contract	1 year
Maximum
Lessee, Lease, Description [Line Items]
Term of contract	10 years

Leases - Schedule of Lease, Cos

Leases - Schedule of Lease, Cost (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Leases [Abstract]
Operating lease cost	$ 4,492	$ 3,360	$ 12,005	$ 10,253
Variable lease cost	847	578	2,297	1,838
Short-term lease cost	39	444	424	1,564
Total net lease cost	$ 5,378	$ 4,382	$ 14,726	$ 13,655

Leases - Maturities of Operatin

Leases - Maturities of Operating Lease Liabilities (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
Remainder of 2024	$ 2,537
2025	16,181
2026	15,378
2027	14,414
2028	13,002
Thereafter	63,184
Total future undiscounted lease payments	124,696
Less: imputed interest	(33,659)
Less: tenant improvement allowance not yet received	0
Total reported lease liability	$ 91,037

Leases - Lease Terms and Discou

Leases - Lease Terms and Discount Rates (Details)	Oct. 31, 2023
Leases [Abstract]
Weighted-average remaining lease term (years)	8 years 1 month 6 days
Weighted-average discount rate	7.10%

Leases - Other Information for

Leases - Other Information for the Company's Leases (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Leases [Abstract]
Cash paid for amounts included in the measurement of lease liabilities	$ 9,190	$ 7,199
Operating lease right-of-use assets obtained in exchange for new operating lease liabilities	$ 45,267	$ 0

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Income Tax Expense (Benefit)	$ 385	$ (391)	$ 1,318	$ (342)
Effective tax rate	(1.30%)	1.10%	(1.30%)	0.30%

Net Loss Per Share - Schedule o

Net Loss Per Share - Schedule of Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Numerator:
Net loss attributable to Braze, Inc.	$ (30,741)	$ (33,360)	$ (100,889)	$ (105,515)
Denominator:
Weighted-average shares of Braze, Inc. common stock outstanding, basic (in shares)	97,880	94,492	97,619	94,201
Less: weighted-average unvested shares of Braze, Inc. subject to repurchase (in shares)	0	(23)	(4)	(33)
Weighted-average shares used to compute net loss per share attributable to Braze, Inc. common stockholders, basic (in shares)	97,880	94,469	97,615	94,168
Weighted-average shares used to compute net loss per share attributable to Braze, Inc. common stockholders, diluted (in shares)	97,880	94,469	97,615	94,168
Net loss per share:
Net loss per share attributable to Braze, Inc. common stockholders, basic (in dollars per share)	$ (0.31)	$ (0.35)	$ (1.03)	$ (1.12)
Net loss per share attributable to Braze, Inc. common stockholders, diluted (in dollars per share)	$ (0.31)	$ (0.35)	$ (1.03)	$ (1.12)

Net Loss Per Share - Schedule_2

Net Loss Per Share - Schedule of Potentially Dilutive Securities (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share (in shares)	13,267	12,426	13,267	12,522
Options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share (in shares)	6,419	8,681	6,419	8,681
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share (in shares)	6,739	3,727	6,739	3,727
ESPP shares estimated to be purchased
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share (in shares)	109	18	109	114

Related Party Transactions - Na

Related Party Transactions - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Related Party Transactions [Abstract]
Purchases from related party	$ 0.4	$ 0	$ 1.6	$ 1

Restructuring (Details)

Restructuring (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring costs	$ 0	$ 0.6

Business Combination (Details)

Business Combination (Details) - USD ($) $ in Thousands	Jun. 01, 2023	Oct. 31, 2023	Jan. 31, 2023
Business Acquisition [Line Items]
Contingent consideration		$ 1,795
Goodwill		28,112	$ 0
North Star Y, Pty Ltd
Business Acquisition [Line Items]
Consideration transferred	$ 28,400
Purchase price consideration, cash payments	17,600
Purchase price consideration, equity issued	6,100
Contingent consideration	1,800
Earn out payment, period one	10,000
Earn out payment, period two	16,000
Intangible assets	3,800
Goodwill	$ 28,100
Indemnification holdback		2,800
Working capital holdback		500
Working capital holdback, amount released		$ 200

Intangible Assets, Net - Schedu

Intangible Assets, Net - Schedule of Intangible Assets, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Jan. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 3,770		$ 3,770
Accumulated Amortization	(363)		(363)	$ 0
Total	3,407		3,407
Non-amortizable intangible assets	500		500	500
Total intangible assets, gross	4,270		4,270	500
Intangible assets, net	3,907		3,907	$ 500
Intangible amortization expense	200	$ 0	400
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	3,119		3,119
Accumulated Amortization	(130)		(130)
Total	$ 2,989		$ 2,989
Amortization Period	10 years		10 years
Restrictive covenant relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 186		$ 186
Accumulated Amortization	(39)		(39)
Total	$ 147		$ 147
Amortization Period	2 years		2 years
Trademark
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 465		$ 465
Accumulated Amortization	(194)		(194)
Total	$ 271		$ 271
Amortization Period	1 year		1 year

Intangible Assets, Net - Sche_2

Intangible Assets, Net - Schedule of Future Amortization Expense (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2024	$ 217
2025	560
2026	343
2027	312
2028	312
Thereafter	1,663
Total	$ 3,407

Goodwill (Details)

Goodwill (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2023 USD ($)
Goodwill [Roll Forward]
Balance at January 31, 2023	$ 0
North Star addition and related adjustments (1)	28,112
Balance at October 31, 2023	$ 28,112

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ in Millions	1 Months Ended	9 Months Ended
	Nov. 30, 2023	Oct. 31, 2023
RSUs
Subsequent Event [Line Items]
Restricted stock granted during the period (in shares)		3,864,954
Subsequent Event
Subsequent Event [Line Items]
Shares donated	32,155
Donation of shares, operating expense	$ 1.4
Subsequent Event | RSUs
Subsequent Event [Line Items]
Restricted stock granted during the period (in shares)	100,928
Award vesting period	4 years
Aggregate value, outstanding	$ 4.8